CLASS II Device recall · Reported 22 May 2019 · FDA Enforcement Report

Terumo Advanced Perfusion System 1 Electronic Patient Gas System recalled

Terumo Cardiovascular Systems is recalling Terumo Advanced Perfusion System 1 Electronic Patient Gas System, distributed nationwide in the US. The recall was initiated on 18 Apr 2019 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesAll
Quantity recalled1258

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1337-2019
FDA event ID
82630
Recalling firm
Terumo Cardiovascular Systems, Ann Arbor, MI
Classification
Class II
Status
Terminated
Recall initiated
18 Apr 2019
FDA classified
15 May 2019
Reported
22 May 2019
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Labeling Errors
Device type
Patient Monitors

Timeline

18 Apr 2019Recall initiated by company
15 May 2019Classified by FDA+27 days
22 May 2019Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The gas flow rate output of the EPGS may be inaccurate due to a defect in the internal flowmeter.

Product as listed by the FDA

Terumo Advanced Perfusion System 1 Electronic Patient Gas System, Catalog # 801188, UDI 00886799000588 The electronic gas blender provides control and monitoring of the gas flow rate and oxygen content of the gas input to the oxygenator in the perfusion circuit.

Where it was distributed

Worldwide Distribution: US (nationwide) and countries of: Australia, Belgium, Canada, Chile, Hong Kong, Indonesia, Japan, Mexico, Philippines, Singapore, South Korea, Taiwan, Thailand, and United Arab Emirates.

Nationwide

Questions about this recall

Why was it recalled?

The gas flow rate output of the EPGS may be inaccurate due to a defect in the internal flowmeter.

Which lots are affected?

All

Where was it sold?

Worldwide Distribution: US (nationwide) and countries of: Australia, Belgium, Canada, Chile, Hong Kong, Indonesia, Japan, Mexico, Philippines, Singapore, South Korea, Taiwan, Thailand, and United Arab Emirates.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Terumo Cardiovascular Systems

All 222

Other Patient Monitors recalls

All 1,014